Catherine H L Hong1, Shijia Hu2, Thijs Haverman3, Monique Stokman4, Joel J Napeñas5, Jacolien Bos-den Braber5, Erich Gerber6, Margot Geuke7, Emmanouil Vardas8, Tuomas Waltimo9, Siri Beier Jensen10,11, Deborah P Saunders12. 1. Faculty of Dentistry, National University of Singapore, Singapore, Singapore. denchhl@nus.edu.sg. 2. Faculty of Dentistry, National University of Singapore, Singapore, Singapore. 3. Department of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, Gustav Mahlerlaan 3004, 1081 LA, Amsterdam, The Netherlands. 4. Department of Radiation Oncology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. 5. Department of Oral Medicine, Carolinas HealthCare System, PO Box 32861, Charlotte, NC, 28232-2861, USA. 6. Kaiser Franz Josef Spital, Institue for Radioonkologie, Vienna, Austria. 7. Department of Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 8. Clinic of Hospital Dentistry, School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece. 9. Department for Preventive Dentistry and Oral Microbiology, University Center for Dental Medicine Basel, University of Basel, Basel, Switzerland. 10. Department of Dentistry and Oral Health, Aarhus University, Vennelyst Boulevard 9, DK-8000, Aarhus C, Denmark. 11. Oral Medicine, Department of Odontology, University of Copenhagen, Nørre Allé 20, DK-2200, Copenhagen N, Denmark. 12. Dental Oncology Program, Health Sciences North, North East Cancer Center, 41 Ramsey Lake Road, Sudbury, ON, P3E 5J1, Canada.
Abstract
INTRODUCTION: This systematic review aims to update on the prevalence of odontogenic-related infections and the efficacy of dental strategies in preventing dental-related complications in cancer patients since the 2010 systematic review. REVIEW METHOD: A literature search was conducted in the databases MEDLINE/PubMed and EMBASE for articles published between 1 January 2009 and 30 June 2016. Each study was assessed by 2 reviewers and the body of evidence for each intervention was assigned an evidence level. RESULTS: After examination of the abstracts and full-text articles, 59 articles satisfied the inclusion criteria. The weighted prevalence of dental infections and pericoronitis during cancer therapy was 5.4 and 5.3%, respectively. The frequency of dental-related infections during intensive chemotherapy after complete, partial, and minimal pre-cancer dental evaluation/treatment protocols ranged from 0 to 4%. Protocols involving third molars extractions had the highest complications (40%). CONCLUSIONS: In view of the low prevalence of infections and the potential for complications after third molar extractions, it is suggested that partial dental evaluation/treatment protocols prior to intensive chemotherapy; whereby minor caries (within dentin), asymptomatic third molars or asymptomatic teeth without excessive probing depth (<8 mm), mobility (mobility I or II) or with periapical lesions of <5 mm were observed; is a viable option when there is insufficient time for complete dental evaluation/treatment protocols. The use of chlorhexidine, fluoride mouth rinses as well as composite resin, resin-modified glass ionomer cement (GIC), and amalgam restorations over conventional GIC in post head and neck radiation patients who are compliant fluoride users is recommended.
INTRODUCTION: This systematic review aims to update on the prevalence of odontogenic-related infections and the efficacy of dental strategies in preventing dental-related complications in cancerpatients since the 2010 systematic review. REVIEW METHOD: A literature search was conducted in the databases MEDLINE/PubMed and EMBASE for articles published between 1 January 2009 and 30 June 2016. Each study was assessed by 2 reviewers and the body of evidence for each intervention was assigned an evidence level. RESULTS: After examination of the abstracts and full-text articles, 59 articles satisfied the inclusion criteria. The weighted prevalence of dental infections and pericoronitis during cancer therapy was 5.4 and 5.3%, respectively. The frequency of dental-related infections during intensive chemotherapy after complete, partial, and minimal pre-cancer dental evaluation/treatment protocols ranged from 0 to 4%. Protocols involving third molars extractions had the highest complications (40%). CONCLUSIONS: In view of the low prevalence of infections and the potential for complications after third molar extractions, it is suggested that partial dental evaluation/treatment protocols prior to intensive chemotherapy; whereby minor caries (within dentin), asymptomatic third molars or asymptomatic teeth without excessive probing depth (<8 mm), mobility (mobility I or II) or with periapical lesions of <5 mm were observed; is a viable option when there is insufficient time for complete dental evaluation/treatment protocols. The use of chlorhexidine, fluoride mouth rinses as well as composite resin, resin-modified glass ionomer cement (GIC), and amalgam restorations over conventional GIC in post head and neck radiationpatients who are compliant fluoride users is recommended.
Authors: C A Gürgan; M Özcan; Ö Karakuş; G Zincircioğlu; M Arat; E Soydan; P Topcuoglu; G Gürman; H S Bostancı Journal: Int J Dent Hyg Date: 2012-04-09 Impact factor: 2.477
Authors: Saad Usmani; Linda Choquette; Robert Bona; Richard Feinn; Zainab Shahid; Rajesh V Lalla Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2018-01-11
Authors: Laura W J Baijens; Margaret Walshe; Leena-Maija Aaltonen; Christoph Arens; Reinie Cordier; Patrick Cras; Lise Crevier-Buchman; Chris Curtis; Wojciech Golusinski; Roganie Govender; Jesper Grau Eriksen; Kevin Hansen; Kate Heathcote; Markus M Hess; Sefik Hosal; Jens Peter Klussmann; C René Leemans; Denise MacCarthy; Beatrice Manduchi; Jean-Paul Marie; Reza Nouraei; Claire Parkes; Christina Pflug; Walmari Pilz; Julie Regan; Nathalie Rommel; Antonio Schindler; Annemie M W J Schols; Renee Speyer; Giovanni Succo; Irene Wessel; Anna C H Willemsen; Taner Yilmaz; Pere Clavé Journal: Eur Arch Otorhinolaryngol Date: 2020-12-19 Impact factor: 2.503
Authors: Kelly R V Villafuerte; Felipe T Dantas; Mario Taba; Michel Messora; Francisco J Candido Dos Reis; Hélio H A Carrara; Cristhiam de Jesus H Martinez; Thais Gozzo; Daniela Bazan Palioto Journal: Support Care Cancer Date: 2021-06-08 Impact factor: 3.603
Authors: Mara Luana Batista Severo; Stéfanie Thieme; Felipe Martins Silveira; Raquel Padilha Martins Tavares; Amanda Katarinny Goes Gonzaga; Silvana Maria Zucolotto; Aurigena Antunes de Araújo; Marco Antonio Trevizani Martins; Manoela Domingues Martins; Éricka Janine Dantas da Silveira Journal: Support Care Cancer Date: 2021-11-25 Impact factor: 3.603
Authors: Juliana Arid; Regina Guenka Palma-Dibb; Harley Francisco de Oliveira; Paulo Nelson-Filho; Fabricio Kitazono de Carvalho; Lea Assed Bezerra da Silva; Talitha de Siqueira Mellara; Raquel Assed Bezerra da Silva; Juliana Jendiroba Faraoni; Alexandra Mussolino de Queiroz Journal: Support Care Cancer Date: 2019-04-24 Impact factor: 3.603